Lexicon Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Lexicon Pharmaceuticals, Inc.

Jul-31	Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement LXRX GlobeNewswire
Jul-23	Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 LXRX GlobeNewswire
Jul-18	Lexicon to Present Patient-reported Data on Diabetic Peripheral Neuropathic Pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025) LXRX GlobeNewswire
Jun-23	Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA) LXRX GlobeNewswire
Jun-18	Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA) LXRX GlobeNewswire
May-29	Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference LXRX GlobeNewswire
May-19	SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology LXRX GlobeNewswire
May-13	Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates LXRX GlobeNewswire
May-06	Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference LXRX GlobeNewswire
May-06	Lexicon Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 LXRX GlobeNewswire